Top 10 Medical Stocks To Buy Right Now

tags:HOME,SFST,ODFL,CNTY,MRK,MMM,SRNE,EDR,TOR,CBL,

Ziopharm Oncology (NASDAQ:ZIOP) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released on Saturday.

According to Zacks, “ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment. “

Get Ziopharm Oncology alerts:

A number of other analysts have also issued reports on the company. BidaskClub lowered Ziopharm Oncology from a “sell” rating to a “strong sell” rating in a research note on Thursday, January 11th. ValuEngine lowered Ziopharm Oncology from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 1st. Finally, HC Wainwright set a $10.00 price target on Ziopharm Oncology and gave the stock a “buy” rating in a research note on Monday, March 5th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $7.50.

Top 10 Medical Stocks To Buy Right Now: Home Federal Bancorp Inc.(HOME)

Advisors' Opinion:

• [By Motley Fool Transcribing]

  At Home Group Inc. (NYSE:HOME) Q2 2019 Earnings Conference CallAug. 29, 2018 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator 

• [By Logan Wallace]

  TRADEMARK VIOLATION WARNING: “Positive News Coverage Somewhat Unlikely to Affect At Home (HOME) Stock Price” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3356638/positive-news-coverage-somewhat-unlikely-to-affect-at-home-home-stock-price.html.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on At Home Group (HOME)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Get a free copy of the Zacks research report on At Home Group (HOME)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  At Home Group Inc (NYSE:HOME) insider Norman E. Mcleod sold 2,592 shares of the stock in a transaction on Thursday, September 20th. The shares were sold at an average price of $33.24, for a total value of $86,158.08. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Top 10 Medical Stocks To Buy Right Now: Southern First Bancshares Inc.(SFST)

Advisors' Opinion:

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Southern First Bancshares (SFST)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  DBS Grp HOLDING/S (OTCMKTS: DBSDY) and Southern First Bancshares (NASDAQ:SFST) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, profitability and institutional ownership.

• [By Shane Hupp]

  Southern First Bancshares (NASDAQ:SFST) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Wednesday.

Top 10 Medical Stocks To Buy Right Now: Old Dominion Freight Line, Inc.(ODFL)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Old Dominion Freight Line (ODFL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Jon C. Ogg]

  Old Dominion Freight Line Inc. (NASDAQ: ODFL) was started as Buy at Argus.

  ALSO READ: Companies With the Best and Worst Reputations

  Rio Tinto PLC (NYSE: RIO) was downgraded to Hold from Buy at HSBC.

• [By Ethan Ryder]

  Investors sold shares of Old Dominion Freight Line (NASDAQ:ODFL) on strength during trading hours on Monday. $15.84 million flowed into the stock on the tick-up and $66.82 million flowed out of the stock on the tick-down, for a money net flow of $50.98 million out of the stock. Of all stocks tracked, Old Dominion Freight Line had the 12th highest net out-flow for the day. Old Dominion Freight Line traded up $1.37 for the day and closed at $158.14

Top 10 Medical Stocks To Buy Right Now: Century Casinos, Inc.(CNTY)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Century Casinos (CNTY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  News headlines about Century Casinos (NASDAQ:CNTY) have been trending somewhat positive on Wednesday, according to Accern Sentiment. Accern rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Century Casinos earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.6738306029486 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

• [By Joseph Griffin]

  ValuEngine upgraded shares of Century Casinos (NASDAQ:CNTY) from a hold rating to a buy rating in a report issued on Thursday.

  Several other research firms have also recently issued reports on CNTY. Zacks Investment Research raised shares of Century Casinos from a sell rating to a hold rating in a research note on Tuesday, January 30th. TheStreet cut shares of Century Casinos from a b rating to a c+ rating in a research note on Friday, April 6th. Finally, BidaskClub cut shares of Century Casinos from a hold rating to a sell rating in a research report on Tuesday, February 6th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $11.00.

Top 10 Medical Stocks To Buy Right Now: Merck & Company, Inc.(MRK)

Advisors' Opinion:

• [By Logan Wallace]

  Merck KGaA (FRA:MRK) has been assigned a €90.00 ($104.65) target price by analysts at JPMorgan Chase & Co. in a report released on Thursday. The brokerage currently has a “neutral” rating on the healthcare company’s stock. JPMorgan Chase & Co.’s target price indicates a potential downside of 0.42% from the company’s previous close.

• [By JJ Kinahan]

  This was one of the bigger weeks for earnings, but next week there are still quite a few major companies reporting:

  Pfizer Inc. (NYSE: PFE) and Merck & Co., Inc. (NYSE: MRK) both report before the open on Tuesday, May 1 Apple Inc. (NASDAQ: AAPL) reports after the close on Tuesday, May 1 Tesla Inc. (NASDAQ: TSLA) reports after the close on Wednesday, May 2 Alibaba Group Holding Ltd. (NYSE: BABA) reports before the open on Friday, May 4

  For a look at what else is going on, check out today’s market update.

• [By Jon C. Ogg]

  Merck & Co. Inc. (NYSE: MRK) was raised to Buy from Neutral at Goldman Sachs. The shares closed up 0.3% at $58.83 on Friday but were indicated up 2.2% at $60.15. Merck has a consensus target price of $66.55.

• [By Keith Speights]

  Merck (NYSE:MRK) topped analysts' consensus earnings estimates every time the company reported quarterly results in 2018. That's one of the reasons why Merck's share price soared nearly 36% last year.

• [By Ethan Ryder]

  Merck & Co., Inc. (NYSE:MRK) – Analysts at SunTrust Banks lifted their Q2 2018 earnings estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Tuesday, June 5th. SunTrust Banks analyst J. Boris now anticipates that the company will post earnings of $1.07 per share for the quarter, up from their previous estimate of $1.06. SunTrust Banks also issued estimates for Merck & Co., Inc.’s Q3 2018 earnings at $1.14 EPS, Q4 2018 earnings at $1.04 EPS, FY2019 earnings at $4.63 EPS, FY2020 earnings at $5.05 EPS, FY2021 earnings at $5.70 EPS and FY2022 earnings at $6.02 EPS.

• [By Keith Speights]

  Like Opdivo, Merck's (NYSE:MRK) Keytruda is a blockbuster cancer immunotherapy, which generated U.S. sales of more than $2.3 billion in 2017. Merck raked in another $1.5 billion from Keytruda in markets outside of the U.S. Keytruda is picking up even more momentum in 2018, with total worldwide Q1 sales of nearly $1.5 billion -- up 151% year over year.

Top 10 Medical Stocks To Buy Right Now: 3M Company(MMM)

Advisors' Opinion:

• [By Neha Chamaria]

  So, below is a list of the top 10 dividend kings by yield. A point to note is that the highest-yielding dividend kings may not necessarily have grown their dividends at the fastest pace, which is why I have included the 10-year dividend compound annual growth rate (CAGR) data for each stock to give you a broader view. 

  Dividend King Current Yield 10-Year Dividend CAGR Payout Ratio (TTM) Procter & Gamble  3.9% 7.7% 72.2% Coca-Cola 3.5% 8.1% 440.7% Federal Realty Investment Trust  3.5% 5.3% 97.6% Genuine Parts Company 3.1% 6.3% 62.7% Northwest Natural Gas 3.1% 2.7% NA* Cincinnati Financial Corporation  3% 3.5% 49.6% Emerson Electric  2.7% 6.2% 69% 3M Company (NYSE:MMM) 2.7% 9.4% 70.4% Colgate-Palmolive Company 2.7% 8.6% 73.6% Johnson & Johnson 2.6% 7.4% 724.9%

  TTM: Trailing 12 months. NA = Not applicable as Northwest Natural Gas incurred a loss per share in TTM primarily because of tax implications. Data sources: YCharts and Yahoo! Finance. Table by author.

• [By Paul Ausick]

  The second-worst Dow stock so far this year is General Electric Co. (NYSE: GE), which is down 19.2%. That is followed by Walmart Inc. (NYSE: WMT), down 16%, 3M Co. (NYSE: MMM), down 15.2%, and Johnson & Johnson (NYSE: JNJ), down 13.2%. Losers outnumber winners for the year to date on the Dow by a score of 19 to 11.

• [By Paul Ausick]

  3M Company (NYSE: MMM) traded down 2.91% at $216.66 in a 52-week range of $188.62 to $259.77. Volume of about 3.3 million shares was around 30% above the daily average. The company had no specific news Friday.

• [By Logan Wallace]

  Sawgrass Asset Management LLC decreased its position in shares of 3M Co (NYSE:MMM) by 29.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,974 shares of the conglomerate’s stock after selling 36,053 shares during the quarter. Sawgrass Asset Management LLC’s holdings in 3M were worth $17,306,000 as of its most recent SEC filing.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on 3M (MMM)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: Sorrento Therapeutics, Inc.(SRNE)

Advisors' Opinion:

• [By Keith Speights]

  Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are down 10.2% as of 3:12 p.m. EDT Thursday on higher-than-average volume, but it's not clear what's going on with the biotech. Sorrento announced on Tuesday morning that it was acquiring Kimberly Clark's Sofusa lymphatic delivery technology, which consists of nano-structured microneedles to deliver drugs into lymphatic capillaries beneath the skin.

• [By William Romov]

  San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

  On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential "game-changer."

• [By Maxx Chatsko]

  Shares of Sorrento Therapeutics (NASDAQ:SRNE) dropped nearly 21% last month, according to data provided by S&P Global Market Intelligence. The stock's September slide was triggered by an announcement that the company's majority-owned subsidiary Scilex entered into a debt-financing deal that would provide $140 million.

• [By Ethan Ryder]

  Sorrento Therapeutics Inc (NASDAQ:SRNE) shares gapped down before the market opened on Monday . The stock had previously closed at $6.75, but opened at $6.55. Sorrento Therapeutics shares last traded at $6.35, with a volume of 2670350 shares traded.

• [By Shane Hupp]

  Sorrento Therapeutics Inc (NASDAQ:SRNE) was up 5.7% during mid-day trading on Tuesday . The stock traded as high as $5.65 and last traded at $5.55. Approximately 1,121,081 shares traded hands during trading, a decline of 58% from the average daily volume of 2,692,661 shares. The stock had previously closed at $5.25.

• [By Logan Wallace]

  Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) fell 7.5% during mid-day trading on Wednesday . The stock traded as low as $4.90 and last traded at $4.95. 1,887,315 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 2,557,091 shares. The stock had previously closed at $5.35.

Top 10 Medical Stocks To Buy Right Now: Education Realty Trust Inc.(EDR)

Advisors' Opinion:

• [By Lisa Levin]

  On Wednesday, the real estate shares surged 0.87 percent. Meanwhile, top gainers in the sector included Innovative Industrial Properties, Inc. (NYSE: IIPR), up 3 percent, and Education Realty Trust, Inc. (NYSE: EDR) up 3 percent.

• [By Ethan Ryder]

  Goldman Sachs Group reiterated their neutral rating on shares of Education Realty Trust (NYSE:EDR) in a research report sent to investors on Thursday.

• [By Ethan Ryder]

  Endor Protocol (CURRENCY:EDR) traded up 4.7% against the US dollar during the twenty-four hour period ending at 13:00 PM ET on September 23rd. Over the last week, Endor Protocol has traded 18.1% higher against the US dollar. One Endor Protocol token can currently be bought for approximately $0.0718 or 0.00001074 BTC on exchanges including Bilaxy, Kucoin, IDEX and DEx.top. Endor Protocol has a total market cap of $38.92 million and $776,781.00 worth of Endor Protocol was traded on exchanges in the last 24 hours.

• [By Joseph Griffin]

  E-Dinar Coin (CURRENCY:EDR) traded 5.2% higher against the U.S. dollar during the twenty-four hour period ending at 19:00 PM ET on August 14th. E-Dinar Coin has a total market cap of $7.78 million and approximately $25,232.00 worth of E-Dinar Coin was traded on exchanges in the last day. One E-Dinar Coin coin can now be bought for about $0.0088 or 0.00000141 BTC on popular exchanges including LocalTrade, Exrates, YoBit and Livecoin. Over the last week, E-Dinar Coin has traded down 13% against the U.S. dollar.

• [By Max Byerly]

  Education Realty Trust (NYSE:EDR) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday.

Top 10 Medical Stocks To Buy Right Now: Sutor Technology Group Limited(TOR)

Advisors' Opinion:

• [By Logan Wallace]

  Torcoin (TOR) is a PoW/PoS coin that uses the X11 hashing algorithm. Its launch date was July 4th, 2014. Torcoin’s total supply is 1,316,179 coins and its circulating supply is 316,179 coins. The official website for Torcoin is torcoin.org. Torcoin’s official Twitter account is @thetorcoin.

• [By Logan Wallace]

  Torcoin (CURRENCY:TOR) traded flat against the dollar during the one day period ending at 15:00 PM E.T. on September 15th. During the last seven days, Torcoin has traded flat against the dollar. Torcoin has a market cap of $23,561.00 and approximately $0.00 worth of Torcoin was traded on exchanges in the last 24 hours. One Torcoin coin can currently be purchased for about $0.0745 or 0.00000789 BTC on popular cryptocurrency exchanges.

Top 10 Medical Stocks To Buy Right Now: CBL & Associates Properties, Inc.(CBL)

Advisors' Opinion:

• [By Matthew Frankel]

  This is particularly true when it comes to lower-end ("Class B" and "Class C") mall operators like CBL & Associates (NYSE:CBL), just to name one example. CBL operates Class B and C malls in mid-sized markets, and a staggering 60% of its properties have a Sears or J.C. Penney (which isn't in much better shape) occupying an anchor location.

• [By Adam Levine-Weinberg]

  As a result, a wide range of retail REITs, including CBL & Associates Properties (NYSE:CBL), The Macerich Company (NYSE:MAC), Pennsylvania Real Estate Investment Trust (NYSE:PEI), and Washington Prime Group Inc. (NYSE:WPG) have posted big share-price declines over the past three years. Even including the impact of dividends, all four are in negative territory:

• [By Max Byerly]

  Schwab Charles Investment Management Inc. lifted its holdings in shares of CBL & Associates Properties, Inc. (NYSE:CBL) by 19.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,853,945 shares of the real estate investment trust’s stock after buying an additional 638,513 shares during the quarter. Schwab Charles Investment Management Inc. owned about 2.23% of CBL & Associates Properties worth $21,467,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on CBL & Associates Properties (CBL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com